Loraz and Etravirine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Etravirine (etravirine). Common drug interactions include hodgkin's disease among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Etravirine. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Etravirine?

Etravirine has active ingredients of etravirine. eHealthMe is studying from 2,801 Etravirine users. Check the latest studies of Etravirine.

On Jul, 19, 2026

34 people who take Loraz and Etravirine together, and have interactions are studied.

What are the common drug interactions of Loraz and Etravirine, by gender? *:

female:

Hodgkin's disease (cancer originating from white blood cells)
Diarrhoea
Fatigue (feeling of tiredness)
Incoherent (talking in a confused and unclear way)
Muscular weakness (muscle weakness)
Delirium (wild excitement)
Psychotic disorder
Abdominal pain
Blood creatinine increased
Blood glucose increased

male:

Chest pain
Death
Rash erythematous (redness of the skin)
Thrombocytopenia (decrease of platelets in blood)
Urinary retention (the inability to completely or partially empty the bladder)
Vomiting
Acute hepatic failure
Cardiac arrest
Cardiomyopathy (weakening of the heart muscle)
Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)

What are the common drug interactions of Loraz and Etravirine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Blood creatinine increased
Blood phosphorus decreased
Decreased appetite
Diabetes insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function)
Failure to thrive (inadequate weight gain and physical growth in children)
Vomiting
Weight decreased

30-39:

Acute hepatic failure
Cardiac arrest
Cardiomyopathy (weakening of the heart muscle)

40-49:

Chest pain
Death
Abdominal pain
Agitation (state of anxiety or nervous excitement)
Blood phosphorus decreased
Dry mouth
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)

50-59:

Dyspnoea (difficult or laboured respiration)
Fall
Glomerular filtration rate decreased
Glycosuria (excretion of glucose into the urine)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Intervertebral disc disorder (spinal disc disorder)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)
Open wound

60+:

Cellulitis (infection under the skin)
Hodgkin's disease (cancer originating from white blood cells)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

What are the existing conditions these people have? *

Hiv Infection: 22 people, 64.71%
Pain: 11 people, 32.35%
Constipation: 8 people, 23.53%
High Blood Pressure: 3 people, 8.82%
Cardiac Failure Congestive: 3 people, 8.82%
Nausea (feeling of having an urge to vomit): 2 people, 5.88%
Insomnia (sleeplessness): 2 people, 5.88%
Depression: 2 people, 5.88%
Anal Cancer: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Etravirine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously